OverviewChartNewsTraderScreen

PolyPid Ltd/  IL0011326795  /

NASDAQ
2024-05-22  8:41:07 PM Chg. - Volume Bid10:00:01 PM Ask10:00:01 PM High Low
4.6548USD - 1,196
Turnover: 5,122.2800		 4.0600Bid Size: 200 4.7100Ask Size: 500 4.6748 4.6548
GlobeNewswire 05-08 PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 05-01 PolyPid to Participate in Citizens JMP Life Sciences Conference
GlobeNewswire 04-30 PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀...
GlobeNewswire 04-24 PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024
GlobeNewswire 02-28 PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference
GlobeNewswire 02-14 PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-12 PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
GlobeNewswire 01-31 PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on ...
GlobeNewswire 01-04 PolyPid Announces Private Placement for $16 Million in Gross Proceeds
GlobeNewswire 01-04 Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
GlobeNewswire 2023-11-08 PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-11-07 PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors
GlobeNewswire 2023-11-01 PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 202...
GlobeNewswire 2023-10-11 PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
GlobeNewswire 2023-10-09 PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023
GlobeNewswire 2023-10-04 PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PL...
GlobeNewswire 2023-09-22 PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
GlobeNewswire 2023-09-21 PolyPid Announces Successful Commercial Good Manufacturing Practice (GMP) Audit by Israeli Ministry ...
GlobeNewswire 2023-09-20 PolyPid Announces Reverse Share Split
GlobeNewswire 2023-09-19 PolyPid Announces Successful Completion of Manufacturing Process Validation for D-PLEX₁₀₀
GlobeNewswire 2022-03-02 PolyPid Announces 750th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ in Abdomina...
GlobeNewswire 2022-03-01 PolyPid to Present at the Barclays Global Healthcare Conference
GlobeNewswire 2022-02-09 PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
GlobeNewswire 2022-01-26 PolyPid to Report Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights on ...
GlobeNewswire 2022-01-04 PolyPid Appoints UCSF Brain Tumor Center Director Mitchel S. Berger, M.D., to Oncology Advisory Boar...